Zoryana Stoyko
Hematology & Oncology · Northfield, NJNPI 1346689049
Payments from drug & device makers
Across 44 payments — averaging $14.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pharmacyclics LLC, An Abbvie Company$89
- AbbVie$62
- Eisai Inc.$59
- Beigene USA, Inc.$49
- E.r. Squibb & Sons, L.L.C.$43
- Bayer$42
- plus $306 from 17 others
What the payments were for
- Food & beverage$63798%
- Education$122%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pharmacyclics LLC, An Abbvie Company | 6 | $89 |
| AbbVie | 4 | $62 |
| Eisai Inc. | 4 | $59 |
| Beigene USA, Inc. | 3 | $49 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| Bayer | 3 | $42 |
| Pfizer | 2 | $33 |
| GSK | 2 | $31 |
| Aadi Bioscience, Inc. | 2 | $30 |
| Lilly USA, LLC | 2 | $28 |
| Stemline Therapeutics Inc. | 1 | $20 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
| Tempus AI, Inc | 1 | $16 |
| Secura Bio, Inc. | 1 | $15 |
| EMD Serono, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Sanofi | 1 | $13 |
| Incyte Corporation | 1 | $13 |
| Gilead | 1 | $12 |
| Deciphera Pharmaceuticals Inc. | 1 | $12 |
| Array Biopharma Inc | 1 | $12 |
| Bio Products Laboratory USA, Inc. | 1 | $11 |
How this compares
$649 in reported general payments places this provider in the 20th percentile of 362 hematology & oncology providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrukinsaZanubrutinib | 12 | $182,187 |
| Letrozole | 23 | $529 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Beigene USA, Inc.Brukinsa | $49 | $182,18712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 362 hematology & oncology providers in New Jersey.
Other hematology & oncology in Northfield
- Bruno FangEast Brunswick$8.5M
- Charles FarberMorristown$4.6M
- Rajat BannerjiNew Brunswick$3.3M
- Eleonora TeplinskyParamus$2.6M
- Mohamad CherryMorristown$1.9M
- Evan NaylorManahawkin$1.3M
- James OrsiniBelleville$1.3M
- Eli KirshnerWestwood$1.2M
- Linda DanieuLivingston$1.2M
- Steven PapishMorristown$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.